Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

FDA requests phase III trials prior to Metvix approval in basal cell carcinoma

Dec. 9, 2004

Selective, orally active VEGF receptor inhibitor effective against human lung cancer in murine model

Dec. 9, 2004

Beneficial effects of curcumin may be mediated in part by iron chelation

Dec. 9, 2004

Identification of two Candida albicans formins

Dec. 9, 2004

Shark tissue extract shown to have antitumor activity in vitro

Dec. 9, 2004

Xencor and Genentech collaborate on next-generation therapeutic antibodies

Dec. 9, 2004

New data on mechanism of action of PCK-3145

Dec. 7, 2004

Fast track designation for CG-53135 for prevention of oral mucositis

Dec. 7, 2004

ODAC votes against recommending approval of Marqibo

Dec. 7, 2004

Imatinib shows activity in AIDS-related Kaposi's sarcoma

Dec. 7, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.